Risk factors of temperature increase after cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy

Risk factors of temperature increase after cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy

BackgroundCytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) is the standard treatment for patients with peritoneal cancer (PC). Following CRS-HIPEC, patients may also face risks caused by whole body hyperthermia. This study analyzed the incidence of temperatur...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron: Hui-xia Kang, Jun-ying Ma, Yan-yan Su, Shan Kang, Bao-jie Feng, Xiao-bei Feng, Xu-sha Wang, Yun-yun Lu
Fformat: Erthygl
Iaith:English
Cyhoeddwyd: Frontiers Media S.A. 2023-03-01
Cyfres:Frontiers in Oncology
Pynciau:
CRS
HIPEC
temperature increase
risk factors
analysis
Mynediad Ar-lein:https://www.frontiersin.org/articles/10.3389/fonc.2023.1120499/full

Rhyngrwyd

https://www.frontiersin.org/articles/10.3389/fonc.2023.1120499/full

Eitemau Tebyg